WASHINGTON, April 3, 2020 /PRNewswire/ -- Danaher
Corporation (NYSE: DHR) ("Danaher") announced today that it has
priced a reopening of:
- €150,000,000 principal amount of additional 1.700% senior notes
due 2024 at an offering price of 100.298% of the principal amount,
plus accrued interest from and including March 30, 2020 (upon closing of this notes
offering, Danaher will have outstanding an aggregate of
€900,000,000 principal amount of 1.700% senior notes due
2024);
- €300,000,000 principal amount of additional 2.100% senior notes
due 2026 at an offering price of 100.842% of the principal amount,
plus accrued interest from and including March 30, 2020 (upon closing of this notes
offering, Danaher will have outstanding an aggregate of
€800,000,000 principal amount of 2.100% senior notes due 2026);
and
- €300,000,000 principal amount of additional 2.500% senior notes
due 2030 at an offering price of 102.166% of the principal amount,
plus accrued interest from and including March 30, 2020 (upon closing of this notes
offering, Danaher will have outstanding an aggregate of
€800,000,000 principal amount of 2.500% senior notes due 2030)
(collectively, the "senior notes").
Each series of new senior notes will have the same terms, other
than issue date and issue price, as the outstanding senior notes,
which Danaher issued on March 30,
2020. They will also have the same ISIN and Common Code
numbers and will trade interchangeably with each respective series
of outstanding senior notes.
Danaher estimates that the net proceeds from the sale of the new
senior notes in the reopening will be approximately €753.7 million,
after deducting the underwriting discounts and estimated offering
expenses payable by Danaher. Danaher anticipates using the net
proceeds for general corporate purposes, which may include
repayment of a portion of its outstanding commercial paper
borrowings as they mature and/or repayment of amounts borrowed
under its revolving credit facilities. The offering is expected to
close on April 8, 2020, subject to
customary closing conditions.
The offering is being made pursuant to an effective shelf
registration statement on file with the U.S. Securities and
Exchange Commission.
The offering of senior notes may be made only by means of a
prospectus and prospectus supplement. A copy of the prospectus and
prospectus supplement relating to the securities can be obtained by
calling BNP Paribas, at 1-800-854-5674, Merrill Lynch International
at 1-800-294-1322, Deutsche Bank AG, London Branch, at 1-800-503-4611, or J.P.
Morgan Securities plc at +44-207-134-2468.
This press release shall not constitute an offer to sell, or the
solicitation of an offer to buy, the senior notes or any other
securities, nor shall there be any offer, solicitation or sale of
any security mentioned in this press release in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
ABOUT DANAHER
Danaher is a global science and technology innovator committed
to helping its customers solve complex challenges and improving
quality of life around the world. Its family of world class brands
has leadership positions in the demanding and attractive health
care, environmental and applied end-markets. With more than 20
operating companies, Danaher's globally diverse team of
approximately 67,000 associates is united by a common culture and
operating system, the Danaher Business System, and its Shared
Purpose, Helping Realize Life's Potential.
FORWARD-LOOKING STATEMENTS
Statements in this release that are not strictly historical,
including the statements regarding the offering of the senior
notes, the anticipated use of proceeds and any other statements
regarding events or developments that we believe or anticipate will
or may occur in the future, may be "forward-looking statements"
within the meaning of the federal securities laws. There are a
number of important factors that could cause actual events to
differ materially from those suggested or indicated by such
forward-looking statements and you should not place undue reliance
on any such forward-looking statements. Additional information
regarding the factors that may cause actual results to differ
materially from these forward-looking statements is available in
Danaher's SEC filings, including Danaher's 2019 Annual Report on
Form 10-K. These forward-looking statements speak only as of the
date of this release and Danaher does not assume any obligation to
update or revise any forward-looking statement, whether as a result
of new information, future events and developments or
otherwise.
View original
content:http://www.prnewswire.com/news-releases/danaher-prices-reopening-of-euro-denominated-senior-notes-301035351.html
SOURCE Danaher Corporation